Xilio Therapeutics, Inc. (XLO)
8.52
+0.07
(+0.83%)
USD |
NASDAQ |
Apr 21, 16:00
8.45
-0.07
(-0.82%)
After-Hours: 20:00
Xilio Therapeutics EPS Diluted (Quarterly) : 0.8077 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| Merck & Co., Inc. | 1.191 |
| Pfizer Inc. | -0.2898 |
| Verastem, Inc. | -0.3947 |
| Sensei Biotherapeutics, Inc. | -3.622 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 10.36M |
| Revenue (Quarterly) | 13.69M |
| Total Expenses (Quarterly) | 3.326M |
| Enterprise Value | -81.31M |
| Gross Profit Margin (Quarterly) | 97.64% |
| Profit Margin (Quarterly) | 75.70% |
| Earnings Yield | -38.17% |
| Normalized Earnings Yield | -39.46 |